Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Neogen's Food Safety Business Thrives on Ergot Alkaloids Test

The newly-developed Reveal Q+ MAX test is likely to fortify Neogen's (NEOG) presence in the global food allergen testing market.

NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
NEOG : 68.35 (-1.14%)
HAE : 116.49 (-0.58%)
Intersect ENT (XENT) Grows on Innovation Despite Cost Woes

The latest offering in Intersect ENT's (XENT) SINUVA portfolio is specific J code - J7401.

XENT : 21.52 (+0.19%)
NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
Walgreens Extends Deal to Form GPO With Retail Giant Kroger

Per Walgreens (WBA), its alliance with Kroger will lead to supply chain efficiencies, capitalizing on their joint resources.

RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
NUVA : 75.84 (+2.69%)
WBA : 57.88 (-1.19%)
Here's Why You Should Hold on to Quest Diagnostics Stock Now

Investors can retain Quest Diagnostics (DGX) stock in their portfolio, thanks to solid prospects.

HAE : 116.49 (-0.58%)
NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
DGX : 105.20 (-0.11%)
Here's Why You Should Add Omnicell to Your Portfolio Now

Investor confidence in Omnicell (OMCL) is at a high, thanks to solid prospects.

OMCL : 79.69 (-1.52%)
HAE : 116.49 (-0.58%)
RMD : 153.63 (+0.91%)
NUVA : 75.84 (+2.69%)
Omnicell (OMCL) Partners With Kit Check to Offer Bluesight

This partnership will offer Omnicell (OMCL) the state-of-the art technology and medication intelligence needed to ensure accurate delivery of drugs to the right patients.

OMCL : 79.69 (-1.52%)
NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
NUVA vs. HAE: Which Stock Should Value Investors Buy Now?

NUVA vs. HAE: Which Stock Is the Better Value Option?

NUVA : 75.84 (+2.69%)
HAE : 116.49 (-0.58%)
Edwards Lifesciences (EW) Plans Strong Long-Term TAVR Growth

Within TAVR, Edwards (EW) expects global TAVR opportunity to exceed $7 billion by 2024.

NUVA : 75.84 (+2.69%)
EW : 232.64 (+0.84%)
HAE : 116.49 (-0.58%)
RMD : 153.63 (+0.91%)
Amedisys (AMED) Benefits From Home Health and Personal Care

Amedisys' (AMED) impressive performance in the newly-unveiled Personal Care segment is appreciative.

RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
NUVA : 75.84 (+2.69%)
AMED : 162.30 (-0.68%)
Thermo Fisher (TMO) at a 52-Week High: What's Driving It?

Thermo Fisher (TMO) gains from solid overseas expansion and acquisitions.

TMO : 320.50 (+0.36%)
HAE : 116.49 (-0.58%)
NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
NuVasive Hits New 52-Week High: What's Driving the Stock?

NuVasive (NUVA) is optimistic about maintaining the momentum on several positive developments.

HAE : 116.49 (-0.58%)
RMD : 153.63 (+0.91%)
NUVA : 75.84 (+2.69%)
EYE : 31.53 (-0.72%)
NuVasive (NUVA) Hits 52-Week High, Can the Run Continue?

NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

NUVA : 75.84 (+2.69%)
EW : 232.64 (+0.84%)
HAE : 116.49 (-0.58%)
NURO : 4.35 (-1.81%)
Myriad Genetics Reports Favorable Study Result on Prequel

Myriad Genetics (MYGN) posts breakthrough results on Prequel Prenatal Screen methodology, proving its superiority over traditional methods.

RMD : 153.63 (+0.91%)
NUVA : 75.84 (+2.69%)
MYGN : 25.58 (+2.32%)
EYE : 31.53 (-0.72%)
Boston Scientific's Watchman Implant Study Results Encourage

These study results are expected to be a major breakthrough for Boston Scientific's (BSX) Cardiovascular segment.

BSX : 45.09 (+0.94%)
NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
NuVasive Advances on Global Footprint Despite Pricing Woes

Within NuVasive's (NUVA) U.S. Spinal Hardware business, a strong uptick in case volume and tangible growth in the XLIF and ALIF franchises are major upsides.

NUVA : 75.84 (+2.69%)
HAE : 116.49 (-0.58%)
RMD : 153.63 (+0.91%)
EYE : 31.53 (-0.72%)
Illumina Inks Deal With ArcherDX to Deliver NGS-Based IVD Kits

Under the contract, ArcherDX will develop IVD tests that will run on Illumina's (ILMN) NextSeq 550Dx System.

NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
ILMN : 324.72 (+0.85%)
Haemonetics (HAE) Launches SafeTrace Tx in North America

Haemonetics (HAE) expands the transfusion management portfolio with SafeTrace Tx, the latest in its transfusion management software product line.

NUVA : 75.84 (+2.69%)
RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
EYE : 31.53 (-0.72%)
Smith & Nephew's JOURNEY II UK Knee System Executes Surgeries

The JOURNEY II UK development is expected to provide a major impetus to Smith & Nephew's (SNN) Orthopedics segment.

NUVA : 75.84 (+2.69%)
SNN : 46.25 (+3.03%)
RMD : 153.63 (+0.91%)
HAE : 116.49 (-0.58%)
HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q3

Buoyed by a solid fiscal third quarter, HealthEquity (HQY) raises its fiscal 2020 view.

TMO : 320.50 (+0.36%)
NUVA : 75.84 (+2.69%)
CNMD : 110.85 (-0.27%)
HQY : 71.46 (-0.20%)
Thermo Fisher Rides on New Product Suite and Global Growth

A series of product launches with better precision medicine initiatives aids Thermo Fisher's (TMO) performance.

TMO : 320.50 (+0.36%)
NUVA : 75.84 (+2.69%)
HAE : 116.49 (-0.58%)
EYE : 31.53 (-0.72%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.68 , AIZ -0.29 , SBAC +7.43 , SO +0.05 , WELL -0.46
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar